These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12109969)

  • 21. Effects of donepezil adjunctive treatment to ziprasidone on cognitive deficits in schizophrenia: a double-blind, placebo-controlled study.
    Fagerlund B; Søholm B; Fink-Jensen A; Lublin H; Glenthøj BY
    Clin Neuropharmacol; 2007; 30(1):3-12. PubMed ID: 17272964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A case of donepezil-related torsades de pointes.
    Kitt J; Irons R; Al-Obaidi M; Missouris C
    BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26438681
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary incontinence: an unrecognised adverse effect with donepezil.
    Hashimoto M; Imamura T; Tanimukai S; Kazui H; Mori E
    Lancet; 2000 Aug; 356(9229):568. PubMed ID: 10950240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [[Donepezil : a new option in the treatment of Alzheimer's disease] ONEPA].
    Azanza JR; Sádaba B; Quetglas EG; Escolar M
    Rev Med Univ Navarra; 1998; 42(2):109-18. PubMed ID: 10420948
    [No Abstract]   [Full Text] [Related]  

  • 25. [Nightmares in patients with Alzheimer's disease caused by donepezil. Therapeutic effect depends on the time of intake].
    Singer M; Romero B; Koenig E; Förstl H; Brunner H
    Nervenarzt; 2005 Sep; 76(9):1127-8, 1129. PubMed ID: 15630600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Switching from donepezil or rivastigmine to galantamine in clinical practice.
    Edwards K; Therriault O'connor J; Gorman C
    J Am Geriatr Soc; 2004 Nov; 52(11):1965. PubMed ID: 15507085
    [No Abstract]   [Full Text] [Related]  

  • 27. FDA is criticised for licensing high dose donepezil.
    Lenzer J
    BMJ; 2011 May; 342():d3270. PubMed ID: 21613347
    [No Abstract]   [Full Text] [Related]  

  • 28. A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia.
    Friedman JI; Adler DN; Howanitz E; Harvey PD; Brenner G; Temporini H; White L; Parrella M; Davis KL
    Biol Psychiatry; 2002 Mar; 51(5):349-57. PubMed ID: 11904128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced lupus erythematosus associated with donepezil: a case report.
    Manzo C; Putignano S
    Age Ageing; 2015 Nov; 44(6):1062-3. PubMed ID: 26420637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatotoxicity Associated with Donepezil in an Individual Taking Citalopram.
    Ma L; Wen C; Chen C; Shen S; Yang J
    J Am Geriatr Soc; 2016 May; 64(5):1144-5. PubMed ID: 27225372
    [No Abstract]   [Full Text] [Related]  

  • 31. Extrapyramidal Symptoms as a Result of Risperidone Discontinuation During Combination Therapy with Methylphenidate in a Pediatric Patient.
    Pérez CA; Garcia SS; Yu RD
    J Child Adolesc Psychopharmacol; 2016 Mar; 26(2):182. PubMed ID: 26871198
    [No Abstract]   [Full Text] [Related]  

  • 32. [Early recognition not hopeless. Alzheimer disease can be delayed].
    MMW Fortschr Med; 2001 Feb; 143(6):60. PubMed ID: 11247376
    [No Abstract]   [Full Text] [Related]  

  • 33. Donepezil-induced linear IgA disease.
    Hussain K; Hepburn NC; Scharrer K; Zdybsky J; Schofield J
    Clin Exp Dermatol; 2012 Jan; 37(1):72-3. PubMed ID: 21689148
    [No Abstract]   [Full Text] [Related]  

  • 34. Donepezil and athetosis in an elderly patient with Alzheimer's disease.
    Tanaka M; Yokode M; Kita T; Matsubayashi K
    J Am Geriatr Soc; 2003 Jun; 51(6):889-90. PubMed ID: 12757588
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: Extrapyramidal side effects with low-dose risperidone.
    Pies R
    Can J Psychiatry; 1997 Oct; 42(8):881. PubMed ID: 9356779
    [No Abstract]   [Full Text] [Related]  

  • 36. Delirium caused by donepezil: a case study.
    Kawashima T; Yamada S
    J Clin Psychiatry; 2002 Mar; 63(3):250-1. PubMed ID: 11926729
    [No Abstract]   [Full Text] [Related]  

  • 37. Unsafe prescription medication switching recommendations.
    Subbiah P; Schwam EM
    Clin Ther; 2001 Dec; 23(12):2050-5. PubMed ID: 11813938
    [No Abstract]   [Full Text] [Related]  

  • 38. Discontinuation syndrome following donepezil cessation.
    Singh S; Dudley C
    Int J Geriatr Psychiatry; 2003 Apr; 18(4):282-4. PubMed ID: 12673601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of donepezil in patients with Alzheimer's disease in assisted living facilities.
    Rosenblatt A; Gao J; Mackell J; Richardson S
    Am J Alzheimers Dis Other Demen; 2010 Sep; 25(6):483-9. PubMed ID: 20558849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of age on response to rivastigmine or donepezil in patients with Alzheimer's disease.
    Bullock R; Bergman H; Touchon J; Gambina G; He Y; Nagel J; Lane R
    Curr Med Res Opin; 2006 Mar; 22(3):483-94. PubMed ID: 16574032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.